BONEX — BoneSupport Holding AB Income Statement
0.000.00%
Last trade - 00:00
- SEK20.87bn
- SEK20.77bn
- SEK591.08m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 155 | 181 | 213 | 329 | 591 |
Cost of Revenue | |||||
Gross Profit | 136 | 162 | 190 | 298 | 541 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 314 | 279 | 294 | 393 | 577 |
Operating Profit | -158 | -98.6 | -80.7 | -64.5 | 13.9 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -158 | -99 | -81.8 | -64.7 | 15.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -161 | -101 | -85.5 | -68.2 | 245 |
Net Income Before Extraordinary Items | |||||
Net Income | -161 | -101 | -85.5 | -68.2 | 245 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -161 | -101 | -85.5 | -68.2 | 245 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.1 | -1.72 | -1.34 | -1.06 | 3.74 |
Dividends per Share |